AV8 Ventures is an early-stage venture capital firm founded in 2018, with offices in Palo Alto, California, and London, United Kingdom. The firm specializes in investing in seed and Series A startups across sectors such as healthcare, enterprise technology, financial services, and deep-tech. Backed by Allianz SE, AV8 Ventures focuses on partnering with visionary entrepreneurs to build category-defining companies.

The firm's team comprises experienced professionals with backgrounds in launching products, building teams, and scaling revenue, offering hands-on support to portfolio companies. Their network includes experts in health, machine learning, enterprise technology, mobility, robotics, hard sciences, and biology, providing comprehensive assistance to startups. Notable investments include Alpha Medical, Delfi Diagnostics, Eclypsium, and Embrace.io.